Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment-Reference-Cited by-同舟云学术

Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment

Published:2022-09 Issue: Volume:26 Page:266-278
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Daniell Henry,Nair Smruti K.,Shi Yao,Wang Ping,Montone Kathleen T.,Shaw Pamela A.,Choi Grace H.,Ghani Danyal,Weaver JoEllen,Rader Daniel J.,Margulies Kenneth B.,Collman Ronald G.,Laudanski Krzysztof,Bar Katharine J.

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference72 articles.

1. ACE2 (Angiotensin-Converting enzyme 2), COVID-19, and ACE inhibitor and Ang II (angiotensin II) receptor blocker use during the pandemic: the pediatric perspective;South;Hypertension,2020

2. Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications;Chatterjee;Clin. Sci. (Lond).,2020

3. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury;Liu;Sci. China Life Sci.,2020

4. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development;Imai;Proc. Natl. Acad. Sci. USA,2020

5. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery;Lores;Clin. Sci. (Lond.),2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation;Molecular Therapy - Methods & Clinical Development;2024-09

2. Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity;Communications Medicine;2024-03-15

3. The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic;Microorganisms;2024-03-14

4. Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort;Frontiers in Cellular and Infection Microbiology;2024-03-05

5. Extracellular vesicles and angiotensin-converting enzyme 2 in COVID-19 disease;BIOCELL;2024